sergolexole maleate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug Namesergolexole maleate
Drug Alias Name麦角克索马来酸盐马来酸麦角克索LY-281067
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonists
TargetsSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsAnxietyMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsAnxietyMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A